Back to search
FDAFDA · Food and drugs·Recall number Z-2552-2025

Brand Name: ReQuest Measles IgM Product Name: Enzyme Linked Immunoabsorbant Assay, Rubeola IgM Model/Catalog Number: 01-190M Software Version: N/A Product Description: Measles IgM tests, performed using ELISA (Enzyme-Linked Immunosorbent Assay) method, used to detect the presence of IgM antibodies against measles virus in a patient's serum or plasma Component: not a component

Published September 17, 2025 · Recall initiated: July 17, 2025

Summary

FDA records medical device Class II recall Z-2552-2025, published September 17, 2025 and initiated July 17, 2025. Recalling firm: Quest International, Inc.; Status: Ongoing; Reported quantity: 376 kits; Lot: UDI I# 00850487007104 - Lots affected: G00024; K04024; M11024; M12024; D01025; E04025,F04025. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Measles IgM Test Kit lacks premarket approval or clearance.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Quest International, Inc.
Distributor
US Nationwide distribution in the states of Utah, Texas, and Arizona.
Lot
UDI I# 00850487007104 - Lots affected: G00024; K04024; M11024; M12024; D01025; E04025,F04025
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Brand Name: ReQuest Measles IgM Product Name: Enzyme Linked Immunoabsorbant Assay, Rubeola IgM Model/Catalog Number: 01-190M Software Version: N/A Product Description: Measles IgM tests, performed using ELISA (Enzyme-Linked Immunosorbent Assay) method, used to detect the presence of IgM antibodies against measles virus in a patient's serum or plasma Component: not a component recalled?

Yes. FDA published recall Z-2552-2025 on September 17, 2025. Reported hazard: Measles IgM Test Kit lacks premarket approval or clearance.

What should I do if I have this product?

Voluntary: Firm initiated · Letter